We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MG:TSXMagna International Inc. Analysis

Data as of 2026-03-13 - not real-time

CA$75.59

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Magna International is trading at C$75.59, comfortably above its 200‑day SMA (C$66.50) but well below the 20‑day (C$85.11) and 50‑day (C$79.01) averages, indicating short‑term weakness in a longer‑term bullish backdrop. The RSI of 35 signals oversold conditions, yet the MACD remains bearish with the line below the signal, and volume is trending down, suggesting limited upside momentum in the near term. The stock sits just above a technical support at C$75.49 and faces a resistance near C$95.18, while its DCF‑derived fair value of roughly C$52 points to a material overvaluation relative to current price. Despite a solid dividend yield of 3.5% and a payout ratio of 66%, the company’s modest 2.1% revenue growth, thin profit margins, and a debt‑to‑equity of 52% temper enthusiasm. Recent news shows the stock has been volatile, with recent declines of 2‑3% on trading days and mixed performance relative to the broader market.
Actionable insight: Investors should treat the near‑term outlook as risky, consider the dividend as a primary attraction, and remain cautious about valuation gaps until clearer growth catalysts emerge.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Price hovering just above technical support
  • Bearish MACD and decreasing volume
  • Overvalued relative to DCF fair value

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Strong dividend yield and payout stability
  • Modest revenue growth and thin margins
  • Volatile price action with upside potential toward resistance

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Exposure to EV and ADAS trends offering growth upside
  • High dividend yield as income anchor
  • Valuation gap requiring earnings acceleration to justify price

Key Metrics & Analysis

Financial Health

Revenue Growth2.10%
Profit Margin1.97%
P/E Ratio19.0
ROE7.13%
ROA4.22%
Debt/Equity52.10
P/B Ratio1.2
Op. Cash FlowCA$3.6B
Free Cash FlowCA$1.3B

Technical Analysis

TrendBullish
RSI35.2
SupportCA$75.49
ResistanceCA$95.18
MA 20CA$85.11
MA 50CA$79.01
MA 200CA$66.50
MACDBearish
VolumeDecreasing
Fear & Greed Index72.7

Valuation

Fair ValueCA$51.93
Target PriceCA$90.36
Upside/Downside19.54%
GradeOvervalued
TypeValue
Dividend Yield3.52%

Risk Assessment

Beta0.82
Volatility58.82%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.